Novavax Tumbles After Report on COVID-19 Vaccine Production Delay

(Reuters) – Shares of Novavax Inc fell 16% after a report from Politico said the company faces significant hurdles in proving it can manufacture its experimental COVID-19 vaccine that meets regulators’ quality standards, resulting in production delays. The methods Novavax used to test the efficacy of its vaccine have fallen short of U.S. regulators’ standards, according to the Politico report, […]
Continue reading »